The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
Open accessAbstract
A new type of pneumonia caused by a novel coronavirus SARS-CoV-2 outbreaks recently in China and spreads into many other countries. This disease, named as COVID-19, is similar to patients infected by SARS-CoV and MERS-CoV, and nearly 20% of patients developed severe condition. Cardiac injury is a prevalent complication of severe patients, exacerbating the disease severity in coronavirus disease 2019 (COVID-19) patients. Angiotensin-converting enzyme 2 (ACE2), the key host cellular receptor of SARS-CoV-2, has been identified in multiple organs, but its cellular distribution in human heart is not illuminated clearly. This study performed the first state-of-art single cell atlas of adult human heart, and revealed that pericytes with high expression of ACE2 might act as the target cardiac cell of SARS-CoV-2. The pericytes injury due to virus infection may result in capillary endothelial cells dysfunction, inducing microvascular dysfunction. And patients with basic heart failure disease showed increased ACE2 expression at both mRNA and protein levels, meaning that if infected by the virus these patients may have higher risk of heart attack and critically ill condition. The finding of this study explains the high rate of severe cases among COVID-19 patients with basic cardiovascular disease; and these results also perhaps provide important reference to clinical treatment of cardiac injury among severe patients infected by SARS-CoV-2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACE2, TMPRSS2, NRP1, integrins, and cathepsins are also expressed on mast cells (Figure 1), 28,29”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [29]
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · cited 5×
“Clinical characteristics of coronavirus disease 2019 in China.”
BackgroundMethodInfluentialYang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066 · cited 1×
“Cardiac injury was observed among 23% of severe patients.(3) Even in the general COVID-19 patient cohort, the creatinine kinase (CK) elevation (>200 U/L) was observed in 13%”
BackgroundDetection of SARS-CoV-2 in Different Types of Clinical Specimens
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020) · JAMA · doi:10.1001/jama.2020.3786 · Cited by 5,116 · cited 1×
“Digestive tract intestine displayed the highest expression of ACE2, followed by testis and kidney, suggesting the vulnerability to virus in these organs, which could explain the positive detection of SARS-CoV-2 in patients’ faeces and urine.(6) The expression of ACE2 in the heart is lower than that in the intestine an…”
BackgroundCD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., Thomas, W. D., Thackray, L. B., Young, M. D., Mason, R. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403812101 · Cited by 611
The Angiopoietin ligands and Tie receptors: potential diagnostic biomarkers of vascular disease
Bilimoria, J., & Singh, H. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1652650 · Cited by 37 · cited 1×
“As the molecular balance between ANGPT1:ANGPT2 and TIE2:TIE1 is important in determining endothelial stability, 7 it is suggested that pericytes play an important role in maintaining EC function in capillary vessels.”
BackgroundChen, L., Yang, F., Chen, X., Rao, M., Zhang, N., Chen, K., Deng, H., Song, J., & Hu, S. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00165 · Cited by 33
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 999
Observations on echocardiographic findings in patients with COVID-19Preprint
Khan, A. A., James, S., Yuan, M., Woolery, L., Huppertz, N., Rahman, M., Varma, C., Apostolakis, S. Z., & Sharma, V. (2020) · Research Square · doi:10.21203/rs.3.rs-58076/v1 · Cited by 3
Ricke‐Hoch, M., Stelling, E., Laßwitz, L., Gunesch, A.-P., Kasten, M., Belinchón, F. J. Z., Brogden, G., Gerold, G., Battmer, K., Pietschmann, T., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-129664/v1 · Cited by 3
Multiplexed detection of SARS-CoV-2 genomic and subgenomic RNA using in situ hybridizationPreprint
Acheampong, K. K., Schaff, D. L., Emert, B. L., Lake, J. I., Reffsin, S., Shea, E. K., Comar, C. E., Litzky, L. A., Khurram, N. A., Linn, R. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.11.455959 · Cited by 3
Khatri, R., Siddqui, G., Sadhu, S., Maithil, V., Vishwakarma, P., Lohiya, B., Goswami, A., Ahmed, S., Awasthi, A., & Samal, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1310197/v1 · Cited by 3
County-Level Longitudinal Clustering of COVID-19 Mortality to Incidence Ratio in the United StatesPreprint
Vahabi, N., Salehi, M., Duarte, J., Mollalo, A., & Michailidis, G. C. (2020) · doi:10.21203/rs.3.rs-40632/v2 · Cited by 3
Balzanelli, M. G., Rastmanesh, R., Distratis, P., Lazzaro, R., Inchingolo, F., Prete, R. D., Pham, V. H., Aityan, S. K., Tran, C. T., Nguyen, K. C. D., et al. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303283480240227113401 · Cited by 2
Assessment of electrolyte abnormalities in older adults with COVID-19 and delirium
Petrovic, M., Park, E., Azhar, G., & Wei, J. Y. (2025) · SAGE Open Medicine · doi:10.1177/20503121251380640 · Cited by 2
Atrial Fibrillation in COVID-19: Mechanisms, Clinical Impact, and Monitoring Strategies
Młynarska, E., Hossa, K., Krupińska, N., Pietruszewska, H., Przybylak, A., Włudyka, K., Rysz, J., & Franczyk, B. (2025) · Biomedicines · doi:10.3390/biomedicines13122889 · Cited by 2
“A study by Chen et al. in 2020 [32] demonstrated that ACE2 is highly expressed in pericytes of adult human hearts, indicating a particular vulnerability of the myocardium to SARS-CoV-2 infection.”
Insights into the renin–angiotensin–aldosterone system in transthyretin amyloid cardiomyopathy
Kronberger, C., Domenig, O., Pávó, N., Kovarik, J. J., Duca, F., Rettl, R., Poledniczek, M., Schmid, L. M., Ermolaev, N., Eslami, M., et al. (2026) · European Journal of Heart Failure · doi:10.1093/ejhf/xuag102 · Cited by 2
Hijacking of GPCRs and angiotensin-converting enzyme-2 in the pathophysiology of infectious diseases
Singh, I. L., Kumar, A., Rajni, E., Keshri, A., Chaudhary, A. K., Dhakad, M. S., Kumar, A., & Sharma, D. (2026) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203261455738 · Cited by 2
Research progress on the association between viruses and cardiac diseases
He-min, Y., Zhu, M.-L., Zhao, Y., Tan, J.-X., Luo, S.-C., Pang, P., & Zheng, C.-B. (2026) · Journal of Virology · doi:10.1128/jvi.00383-26 · Cited by 2
Pandemia del SARS-CoV-2 y reproducción asistida
Borrás, A., Guimerà, M., Barral, Y., Agustí, I., & Manau, D. (2020) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2020.06.004 · Cited by 2
Stancampiano, F. F., Omer, M., Harris, D. M., Valery, J. R., Heckman, M. G., White, L. J., & Libertin, C. R. (2021) · Southern Medical Journal · doi:10.14423/smj.0000000000001269 · Cited by 2
“Angiotensin-converting enzyme 2 receptors are highly expressed in cardiac cells and may represent a target for SARS-CoV-2 that leads tomyocardial injury and clinical disease.(18)Consistentwith a possible mechanism of direct viral invasion and damage to the heart, an autopsy study identified a high number of copies of…”
BackgroundThe Antioxidant Arsenal Against COVID-19
Mudgal, G., Kaur, J., Chand, K., & Singh, G. B. (2021) · Molecular and integrative toxicology · doi:10.1007/978-3-030-83446-3_16 · Cited by 2
Bratilova, E. S., Kachnov, V. A., Tyrenko, V. V., & Николаевна, К. С. (2022) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov87291 · Cited by 2
Jin, M., Li, Z., Li, X., Xie, M., Li, W., Ai, L., Sun, Y., Cheng, X., Sheng, Y., Zhang, J., et al. (2022) · Infezioni in Medicina · doi:10.53854/liim-3002-8 · Cited by 2
Self-citationCarubbi, F., Alunno, A., Carducci, A., Grassi, D., & Ferri, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175248 · Cited by 2
“In addition, since SARSCoV-2 spike protein binds to the membrane-bound form of angiotensin-converting enzyme 2 (ACE2) receptor and ACE2 is expressed in cardiomyocytes, fibroblasts, endothelium, and pericytes, the heart has been proposed as a potential direct target of viral entry [29,30].”
BackgroundEpigenetic modifications and regulation in infection
Brown, J. A., Amir, M., & Zeng, M. Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00002-5 · Cited by 2
Iron Chelation Therapy in COVID-19 Infection: A Review Article
Kmoniček, I. K., Tomić, A., & Kocur, J. (2022) · Southeastern European medical journal · doi:10.26332/seemedj.v6i2.246 · Cited by 2
COVID-19-related cardiac lesion: The questions of pathogenesis and diagnostics
Filatova, D. A., Mershina, E. A., & Sinitsyn, V. E. (2023) · Digital Diagnostics · doi:10.17816/dd284706 · Cited by 2
Retinal and choroidal microvasculature in early and three months post COVID-19: A case-control study
Moshfeghi, S., Khosravifard, K., Shirzadi, K., Makateb, A., Pourazizi, M., Kateb, H., Naderan, M., & Abounoori, M. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103730 · Cited by 2
Myocardial Angiotensin-Converting Enzyme 2 Protein Expression in Ischemic Heart Failure
Siratavičiūtė, V., Pangonytė, D., Utkienė, L., Jusienė, L., Marcinkevičienė, J. E., Stanionienė, Z., & Radikė, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417145 · Cited by 2
“Unexpectedly, pericytes exhibited higher levels of ACE2 expression than cardiomyocytes [22,23].”
BackgroundFerreira‐da‐Silva, R., Maranhao, P. A., Dias, C. C., Alves, J. M., Pires, L., Morato, M., Polónia, J. J., & Ribeiro‐Vaz, I. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116242 · Cited by 2
How COVID-19 Can Damage the Heart? – Association of Cardiac Injury with COVID-19: A Narrative Review
Gregório, C., Caldeira, D., Brito, J., Plácido, R., & Pinto, F. J. (2024) · Heart and Mind · doi:10.4103/hm.hm-d-23-00035 · Cited by 2
Tomar, D., Kapoor, A., Hashim, Z., Raut, K., Katheria, A., Khare, H., Sahu, A. K., Khanna, R., Kumar, S., Garg, N. K., et al. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.09.003 · Cited by 2
The COVID-19 Pandemic: A Challenge for the Cardiovascular Health
Crisafulli, A., & Pagliaro, P. (2020) · Current Cardiology Reviews · doi:10.2174/1573403x1602200519115447 · Cited by 2
Women’s Resilience and Vulnerability in Facing COVID-19 in DKI Jakarta and East Java
Achidsti, A., Sari, O. K., Ratnasari, D. P., Ningsih, N. S., Widyaningrum, A. R., Maji, J. S., Weiss, M. U. S., & Muttaqin, S. S. (2021) · Populasi · doi:10.22146/jp.63388 · Cited by 2
“(Chen et al., 2020).”
Hydrophobic Pocket of SARS-Cov-2 Spike Glycoprotein are Potential as Binding Pocket
Fitri, A., Hidayat, B., & Iryani (2021) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1788/1/012021 · Cited by 2
“SARS-CoV-2 is a novel beta-coronavirus and enters the host cell as SARS-CoV through the Spike glycoprotein (S-glycoprotein) [3].”
BackgroundMaruhashi, T., Wada, T., Masuda, T., Yamaoka, K., & Asari, Y. (2021) · Cureus · doi:10.7759/cureus.13599 · Cited by 2
“COVID-19 causes acute respiratory distress syndrome, and the virus may injure not only the lungs but also various other organs, such as the myocardium, [1] kidney, [2,3] and pancreas [4].”
BackgroundCOVID-19. Su repercusión cardiovascular. Una revisión
Fernández, A., Barisani, J. L., Guetta, J. N., Bosio, M., Chertcoff, J., Marino, J. C., Díez, M., Lescano, A. J., Lucas, L. O., Fairman, E. B., et al. (2020) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v88.i3.18230 · Cited by 2
Dharmawan, A. K., Setyawan, I. A., Triswanti, N., Rusmini, H., Sudiadnyani, N. P., & Izzuddin, A. (2021) · JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM) · doi:10.33024/jkpm.v4i4.3705 · Cited by 2
CLINICAL AND FUNCTIONAL DISORDERS OF CARDIORESPIRATORY SYSTEM IN PATIENTS WITH COVID-19
Smirnova, A. Y., Gnoevykh, V. V., Shorokhova, Y. A., Chernova, N. G., Serov, V. A., & Разин, В. А. (2021) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2021-3-6-18 · Cited by 2
Serezhina, E. K., & Обрезан, А. Г. (2022) · Kardiologiia · doi:10.18087/cardio.2022.3.n1468 · Cited by 2
CARDIOVASCULAR SYSTEM INJURIES IN PATIENTS WITH COVID-19. Review
Moskalyuk, V. D., Randiuk, Y. O., Syrota, B. V., & Balaniuk, I. V. (2022) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.2.2022.07 · Cited by 2
Akbar, S. M. F., Mahtab, M. A., & Khan, S. (2023) · Vaccines · doi:10.3390/vaccines11030615 · Cited by 2
COVID-19 and the Cardiovascular System
Mani, S., & Garcia, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87539-4.00006-3 · Cited by 2
Importancia de los estudios de anatomía patológica en COVID-19
Toscano, A. Á., Bassols, Á. C., & González, J. J. E. (2020) · Medicina Crítica · doi:10.35366/94901 · Cited by 2
Zazerskaya, I. E., Bezhenar, V. F., Олеговна, Г. А., & Ishkaraeva, V. V. (2020) · Journal of obstetrics and women s diseases · doi:10.17816/jowd69429-40 · Cited by 2
“Точно так же ACE2 выраженно экспрессируется на подоцитах и эпителиальных клетках канальцев почки [44, 45].”
InfluentialCardiovascular injuries and SARS-COV-2 infection: focus on elderly people.
Colombo, C., Garatti, L., Ferrante, G., Casadei, F., Montalto, C., Crimi, G., Cogliati, C. B., Ammirati, E., Savonitto, S., & Morici, N. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.07.001 · Cited by 2
Nv, O., Lomaichikov, V. V., Chuvarayan, G. A., Spiryakina, Y. G., Эрнестович, А. С., Titova, I. Y., & Павловна, П. А. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-23-53-57 · Cited by 2
“Повреждение перицитов в резуль тате вирусной инфекции может привести к дисфункции эндотелиальных клеток капилляров, вызывать дисфункцию микрососудов и являться одной из причин острого по вреждения миокарда [18].”
Dixit, A., Giri, N., & Singh, S. H. (2021) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2021-0200 · Cited by 2
A Review on Effectiveness of Plasma Therapy in Severe COVID-19 Patients
Kapil, K., & Gharde, P. M. (2022) · Cureus · doi:10.7759/cureus.28914 · Cited by 2
“microvascular network all contain a significant amount of ACE2 receptor [5-7].”
BackgroundCOVID-19 Impact on Host at Pathophysiological and Cellular Level
Indari, O., Jakhmola, S., Kashyap, D., Baral, B., Verma, T., Jain, K., & Jha, H. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_5 · Cited by 2
Overweight increases COVID-19 morbidity and mortality
High Technology Park, K.-M., Krivosheev, V. V., Stolyarov, A. I., High Technology Park, K.-M., & Nikitina, L. Y. (2022) · Sanitarnyj vrač (Sanitary Doctor) · doi:10.33920/med-08-2211-01 · Cited by 2
Takami, Y., Hoshino, N., Yanase, M., Tanida, S., Inada, K., Tsukamoto, T., Amano, K., Maekawa, A., Izawa, H., & Takagi, Y. (2023) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2023.02.013 · Cited by 2
“The former pathogenesis, directmyocardial injury by SARS-CoV-2, is characterized histopathologically by scattered myocyte necrosis without significant brisk lymphocytic inflammatory infiltrates [4,5], as shown in our patient.”
Coronavirus Disease 2019, Myocardial Injury, and Myocarditis
Xiang, L., Zhang, L., Zhang, T., Zhang, H., Guo, C., Liu, S., Wang, Q., Cai, H., & Lu, Z. (2023) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2023.0025 · Cited by 2
“Notably, people with underlying heart failure have elevated ACE2 expression at both the mRNA and protein levels, and consequently may be at increased risk of heart damage and critical illness when they are infected with SARS-CoV-2 [36].”
BackgroundInsights into COVID-19 and Its Potential Implications for Kidney Dysfunction
Abdel‐Moneim, A., Bakry, E. H., & Zaky, M. Y. (2023) · International Journal of Translational Medicine · doi:10.3390/ijtm3020018 · Cited by 2
“Data from the Genotype-Tissue Expression Project show that the kidneys have signifi-cant levels of ACE2 expression [36].”
BackgroundLarrea divaricataa native Argentine plant with potential activity against SARS-CoV-2?
Alonso, M. R., Marrassini, C., Martin, M. S., Cogoi, L., Peralta, I., & Anedini, C. (2023) · Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas · doi:10.37360/blacpma.23.22.6.52 · Cited by 2
“ACE2 is expressed on epithelial cells of the lung and intestine, and to a lesser extent, in the kidney, heart, adipose, and both male and female reproductive tissues (Zhang et al., 2020; Lamers et al., 2020; Chen et al., 2020a; Jing et al., 2020; Subramanian et al., 2020).”
Ma, X., Liu, L., Sun, J., Zhang, Y., Liu, Y., Liu, M., Wang, B., Chang, Y., Han, Y., & Gai, Z. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.922 · Cited by 2
Natural Products: A Potential New Hope to Defeat Post-acute Sequelae of COVID-19
Zhao, S., Abdurehim, A., Yuan, Y., Tan, Y., Li, C., Zhang, Y., Li, Y., Sun, X., & Xie, J. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230829164156 · Cited by 2
Current status of drug development against SARS CoV-2 infections
Prüß, B. M. (2020) · Medical Research Archives · doi:10.18103/mra.v8i8.2203 · Cited by 2
“Initial research with SARS CoV-2 demonstrated that the rhACE2 drug APN01 inhibited SARS CoV-2 replication in tissue cultures of engineered human cells by 1,000 to 5,000 times [33].”
BackgroundSingle-cell transcriptomics of murine mural cells reveals cellular heterogeneity
Guan, Y., Li, Y., Roosan, M. R., & Jing, Q. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1823-2 · Cited by 3
Cardiac injury and COVID-19: A Review on available present-day literature
Padma, V., Raja, R. B., & Nair, A. B. (2021) · Biomedicine · doi:10.51248/.v40i4.308 · Cited by 2
“colon brain, kidney, nasal and oral mucosa, nasopharynx, skin, muscles around sebaceous glands, basal cell layer of hair follicles and eccrine glands (28, 29).”
BackgroundCardiovascular Disease in the COVID-19 Era: Myocardial Injury and Thrombosis
Amin, A., Sadeghipour, P., & Chitsazan, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-80915-3.00044-2 · Cited by 2
“the ACE2 receptors are expressed on cardiac myocytes, endothelial cells, and pericytes.(18,19) Thismight also contribute to the cardiac damage in SARS-CoV-2 infection, though the exact pathophysiologic mechanisms are still unclear.”
BackgroundAn Overview of a Year with COVID-19: What We Know?
Teodorescu, M. (2021) · Electronic Journal of General Medicine · doi:10.29333/ejgm/9765 · Cited by 2
“As has been reported in SARS-CoV [118] and MERS-CoV cases, SARS-CoV-2 is also a cardiotropic virus, which can directly bind on ACE2 receptors highly expressed in cardiomyocytes, cardiofibroblasts, and coronary endothelial cells [119].”
BackgroundAbnormal Myocardial Enzymes are Important Indicators of Poor Prognosis in COVID-19 Patients
Cheng, J., Liu, W., Chen, S., Hu, X., Xiang, X., Cheng, Z., Cai, S., Guo, K., Wang, Q., Liu, X., et al. (2021) · Future Virology · doi:10.2217/fvl-2020-0304 · Cited by 2
Khalil, S., Collins, A. P., Mubarak, N., & Khalil, T. (2020) · Journal of Cardiology Case Reports · doi:10.15761/jccr.1000159 · Cited by 2
Biswas, M. (2021) · Journal of Virology Research & Reports · doi:10.47363/jvrr/2021(2)129 · Cited by 2
“The ACE2 gene is highly polymorphic and many of the single nucleotide polymorphism (SNP) of this gene had been established as a risk factor for developing cardiovascular diseases [1,2].”
BackgroundResultGonçálves, J. M. F., & Golpe, R. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.04.015 · Cited by 2
Hussain, T., Joyce, J., Habib, S., Tousif, S., Ratnani, S., & Puvvada, S. (2021) · Cureus · doi:10.7759/cureus.20348 · Cited by 2
Hyperferritinemia: the link between COVID-19, inflammation, and patient comorbidities
Lazăr, A. M. (2021) · Journal of Ideas in Health · doi:10.47108/jidhealth.vol4.iss4.193 · Cited by 2
“As ACE2 are the receptors for the SARS-CoV-2 [59], a temporary hypothesis was a higher expression of ACE2 receptors in such diseases, male patients, and older age, increasing the risk and severity of SARS-CoV-2 infection [53, 60-65].”
BackgroundPathogenesis of CoViD19—Miscellaneous Mechanisms
Mallick, U. (2022) · Springer eBooks · doi:10.1007/978-3-030-90065-6_10 · Cited by 2
Coinfección chagas e infección por covid 19 en una paciente indígena
León, J. S. T., delgado, M. C., Garcia, G. N. P., Meriño, Y. M., Badillo, L. Y. E., Caballero, H. V., & Brilla, M. F. G. (2022) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v6i2.2163 · Cited by 2
Cardiovascular Vulnerability to COVID-19 in Cancer SurvivorsPreprint
Zordoky, B. N. M. (2020) · Preprints.org · doi:10.20944/preprints202004.0128.v1 · Cited by 2
“First, Angiotensin Converting Enzyme-2 (ACE2), a key enzyme in the Renin Angiotensin Aldosterone System, has been recognized as a receptor to SARS-CoV-2 [7,8].”
BackgroundInfluentialChen, L., An, S., Yao, G., Xiong, J., Xiong, H., Zhao, P., Jiang, L., Hua, W., Xiong, C., Duru, F., et al. (2020) · doi:10.21203/rs.3.rs-33047/v1 · Cited by 2
Self-citationClifford, S. P., Ramírez, J. A., Akça, O., Ghafghazi, S., & Huang, J. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.01.052 · Cited by 2
COVID-19: extraño nuevo virus, endotelio y enseñanzas de una pandemia
Enrique Melgarejo, R. (2020) · Acta Médica Colombiana · doi:10.36104/amc.2020.1918 · Cited by 2
Endocrinology, Diabetes and Obesity
(2018) · Endocrinology Diabetes and Obesity · doi:10.31532/endocrinoldiabetesobes · Cited by 2
“Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor
Tsigkou, V., Siasos, G., Oikonomou, E. K., Bletsa, E., Vavuranakis, Μ., & Tousoulis, D. (2022) · World Journal of Virology · doi:10.5501/wjv.v11.i4.216 · Cited by 2
Balzanelli, M. G., Distratis, P., Lazzaro, R., Dipalma, G., Inchingolo, F., Prete, R. D., Pham, V. H., Aityan, S. K., Nguyen, K. C. D., & Isacco, C. G. (2023) · Preprints.org · doi:10.20944/preprints202308.1130.v1 · Cited by 1
Velichkov, M., Schulze, P. C., & Otto, S. (2021) · PubMed Central · doi:10.1007/s00108-021-01079-w · Cited by 1
“Das ACE2 wird bei kardialen Erkrankungen hochreguliert, was die Anfälligkeit und Reaktion auf eine SARS-CoV2-Infektion in kardiovaskulär Erkrankten impliziert [25].”
BackgroundSu, K., Huang, X., Xu, K., Du, W., Zhu, D., Yang, M., Yuan, W., & Li, L. (2020) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000025 · Cited by 1
INNOVATIVE APPROACHES IN MEDICINE
International Science Group, & Vladlenov, D. (2020) · Іnternational Science Group eBooks · doi:10.46299/isg.2020.mono.med.iii · Cited by 1
Güneysu, F., Durmuş, E., & Yürümez, Y. (2021) · Sakarya Medical Journal · doi:10.31832/smj.930242 · Cited by 1
Severe Acute Respiratory Syndrome Coronavirus Associated Myocarditis
Wantania, F. E. N., Wowor, R. E., & Tandiawan, R. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.6498 · Cited by 1
“Genetic predisposition appears to also play a role to some extent in inducing arrhythmia in SARS-CoV-2 infection [5], [13] (Figure 2).”
BackgroundFollonier, C., Tessitore, E., Handgraaf, S., Carballo, D., Achard, M., Péchère-Bertschi, A., Mach, F., Herrmann, F. R., & Girardin, F. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277653 · Cited by 1
Noman, A. A., Ekra, J. E., Meem, R. I., Islam, S., Sharzana, F., Islam, S., Sana, S., Mahmud, N., Kabir, M., Mahedi, A. A., et al. (2022) · Journal of Health Research · doi:10.56808/2586-940x.1018 · Cited by 1
Akkari, M. T., Al-Kayali, R., & Ibrahim, A. (2023) · Zagazig Journal of Pharmaceutical Sciences/Zagazig Journal of Pharmaceutical Science · doi:10.21608/zjps.2023.221071.1051 · Cited by 1
Role of Serum NT-proBNP Levels in Early Prediction of Prognosis in Severe COVID-19 Pneumonia
Atmaca, H. U., Çiçek, N. E., & Pişkinpaşa, M. E. (2023) · Istanbul Medical Journal · doi:10.4274/imj.galenos.2023.90094 · Cited by 1
AlTaweel, M., Almusaad, A., Alkhazmari, G., Alrowaily, H., AlSubaiee, M., Husain, M. A., Alomayrin, N., Muaiweed, R. A., Aleid, N., Alarfaj, A. A., et al. (2024) · Archives of Microbiology & Immunology · doi:10.26502/ami.936500177 · Cited by 1
Hatem, B. A., & Jabir, F. A. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10890-7 · Cited by 1
“Chen et al. (2020) investigated the association between ACE2 gene polymorphisms and COVID-19 severity in a Chinese population.”
Post‐acute sequelae of COVID ‐19 in cancer patients: Two cohorts in UK and Hong Kong
Wan, E. Y. F., Lee, S. F., Zhou, J., Yan, V. K. C., Lai, F. T. T., Chui, C. S. L., Li, X., Wong, C. K. H., Chan, E. W., & Wong, I. C. K. (2024) · Cancer Medicine · doi:10.1002/cam4.70134 · Cited by 1
Self-citationCarvalho, M. C., Fernandes, F. E. C. V., Almeida, M. V. D. S., dos Santos, J. M. A., Amestoy, S. C., & de Melo, R. A. (2025) · Revista Latino-Americana de Enfermagem · doi:10.1590/1518-8345.7609.4552 · Cited by 1
COVID-19 as Potential Cause of Aortic Valvulitis
Warren, B., Patel, A., Pasupuleti, S., & Kotwani, R. (2025) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1499 · Cited by 1
“7 Therefore, virus-infected pericytes can lead to capillary endothelial cell dysfunction and, ultimately, impairment in the microcirculation of the cardiovascular tissue.”
Johansen, M. D., Ming, C. L. C., Hansbro, P. M., & Gentile, C. (2026) · Biofabrication · doi:10.1088/1758-5090/ae38d7 · Cited by 1
“These findings agree with earlier studies, which have shown that OAS family genes are significantly elevated in SARS-CoV-2-infected cardiomyocytes and COVID-19 heart failure (Gao et al , 2023).”
InfluentialPotential predictors of COVID-19 disease infection and severity in Egypt
Abdelraheem, W. M., Shady, R. R., Mahdi, W. K. M., Bassyouni, M., Kamel, H. S., Mousa, Y. M., Kamel, S. F., Saber, M. M., & Abdelrahim, S. S. (2026) · Scientific Reports · doi:10.1038/s41598-025-34444-y · Cited by 1
Siliste, R., Benea, S. N., Homentcovschi, C., Deaconu, T., Căruntu, C., & Săvulescu-Fiedler, I. (2026) · Life · doi:10.3390/life16020268 · Cited by 1
“In any case, ACE2 levels in the heart are lower than in the intestine and kidney, but higher than in the lung [6].”
InfluentialFive-year cardiovascular outcomes following COVID-19-associated carditis
Hadidchi, R., Ali, E., Shih, W. K., Zhao, W., Ragupathi, S., Bisulca, J., Le, T. T. B., Henry, S. S., & Duong, T. Q. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-026-02863-0 · Cited by 1
Fonseca, A. L., Oliveira, M. C., Fonseca, D. R. P., Afonso, J. P. R., Paixão, H. N. C., Júnior, J. B. S. R., Alves, L. R., Fernandes, T. V., Marconi, D. G., Andraus, R. A. C., et al. (2026) · COVID · doi:10.3390/covid6050082 · Cited by 1
Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System
Ernzen, K., Trask, A. J., Peeples, M. E., Garg, V., & Zhao, M. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10229-4 · Cited by 1
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac123.39893995 · Cited by 1
SARS-Cov-2 and Associated Heart Failure
Aimrane, A., El‐Mansoury, B., Sabir, E., Baz, S. E., Zouhairi, N., Echchakery, M., Draoui, A., Chatoui, H., Fdil, N., Sellami, S., et al. (2021) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-8225-1.ch010 · Cited by 1
SINDROM COVID-19 YANG MEMANJANG DAN KAITANNYA DENGAN KARDIOVASKULAR: SUDUT PANDANG KARDIOLOG
Laksono, S. (2022) · Medika Kartika Jurnal Kedokteran dan Kesehatan · doi:10.35990/mk.v5n1.p103-111 · Cited by 1
Cerebral venous sinus thrombosis in COVID 19 patients: Report of 2 cases
Taha, M. M., Taha, M. M., Menshawy, H. A. A., & Elsharkawy, A. M. (2022) · Interdisciplinary Neurosurgery · doi:10.1016/j.inat.2022.101599 · Cited by 1
Managing Covid-19 in patients with heart failure: current status and future prospects
Prameswari, H. S., Putra, I. C. S., Raffaello, W. M., Nathaniel, M., Suhendro, A. S., Khalid, A. F., & Pranata, R. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2132230 · Cited by 1
Mechanisms of atrial fibrillation in COVID-19
Moseichuk, K. A., & Филиппов, Е. В. (2023) · Journal of Arrhythmology · doi:10.35336/va-2023-1-11 · Cited by 1
Bogdanov, D. S., Cherkashin, D. V., Ефимов, С. В., & Zakharova, A. I. (2023) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma114802 · Cited by 2
Mishra, K. A., Podili, R., Pathlavath, T. S., & Sethi, K. K. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23409 · Cited by 1
Tissue expression of the SARS-CoV-2 cell receptor gene ACE2 in children
Huang, J., Guo, Z., Duan, J., Zou, Y., Chen, K., Huang, H., Zhang, S., & Zhou, Y. (2023) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmad027 · Cited by 1
Zavyalova, M. V., Neklyudov, A. A., Васильевич, З. А., Сергеевна, А. Е., Михайлович, П. Ю., Вячеславовна, Б. М., Krakhmal, N. V., & Vtorushin, S. V. (2023) · Kardiologiia · doi:10.18087/cardio.2023.8.n2139 · Cited by 1
Metadata
- Authors
- Chen, L., Li, X., Chen, M., Feng, Y., & Xiong, C.
- Affiliations
- Fudan University (CN)
- Renmin University of China (CN)
- Corresponding author
- Chen, Liang
- Xiong, Chenglong
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-03-30
- Volume
- 116
- Issue
- 6
- Pages
- 1097-1100
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC7184507
- OpenAlex
- W3014027512
- Cited by
- 1,163
- References
- 7
- Citations by year
- 2026: 19 · 2025: 32 · 2024: 64 · 2023: 148 · 2022: 210 · 2021: 332 · 2020: 355
- FWCI
- 34.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81872673)
- National Key Research and Development Program of China (2017YFC1200203)
- Fudan University
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- ACE2, SARS-CoV-2, COVID-19 pandemic, cardiac injury, pericytes, microvascular dysfunction, heart failure, viral receptor expression, myocardial injury
- MeSH terms
- Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Heart, Heart Diseases, Humans, Peptidyl-Dipeptidase A, Myocardium, Pneumonia, Viral, Receptors, Virus, Gene Expression, Coronavirus Infections, Pericytes, Gene Expression Profiling, Pandemics, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review